By Josh White
Date: Wednesday 13 Dec 2023
(Sharecast News) - Intellectual property commercialisation specialist Frontier IP Group announced on Wednesday that its portfolio company, The Vaccine Group (TVG), had appointed an advisory board to facilitate the expansion of its herpesvirus-based vaccine platform.
Unaudited Half Year Results | 14-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Mar-2024 | 13:40 | RNS |
Sale of shares in Exscientia | 29-Feb-2024 | 15:12 | RNS |
Holding(s) in Company | 30-Jan-2024 | 11:45 | RNS |
Total Voting Rights | 29-Dec-2023 | 12:00 | RNS |
Frontier IP moves into the black | 04-Mar-2011 | The Scotsman |
Frontier IP move targets new investors | 07-Feb-2011 | Express & Star |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 38.50p |
Change Today | -2.00p |
% Change | -4.94 % |
52 Week High | 70.50 |
52 Week Low | 33.00 |
Volume | 164,591 |
Shares Issued | 56.17m |
Market Cap | £21.62m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:22 | 51 @ 39.00p |
16:18 | 5,000 @ 38.90p |
16:13 | 3,000 @ 38.50p |
14:48 | 36,000 @ 38.50p |
15:47 | 1,632 @ 38.90p |
CEO | Neil Crabb |
Finance Director | James Fisher |
You are here: research